Regencell Bioscience Holdings Ltd (RGC) — Cash Flow-to-Debt Ratio
Regencell Bioscience Holdings Ltd (RGC) has a Cash Flow-to-Debt Ratio of -9.11x as of June 2024, meaning its operating cash flow of $-2.00 Million could theoretically repay -9% of its total liabilities ($219.51K) in one year. See how much free cash does Regencell Bioscience Holdings Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Regencell Bioscience Holdings Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Regencell Bioscience Holdings Ltd across 23 annual periods. Also explore net asset growth rate of Regencell Bioscience Holdings Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Regencell Bioscience Holdings Ltd (2003–2025)
Year-by-year debt coverage analysis for Regencell Bioscience Holdings Ltd. For market capitalisation and broader financial context, see Regencell Bioscience Holdings Ltd (RGC) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.48x | $-3.11 Million | $895.31K | ▲ +80.9% |
| 2024 | -18.23x | $-4.00 Million | $219.51K | ▼ -132.3% |
| 2023 | -7.85x | $-4.96 Million | $632.32K | ▼ -39.8% |
| 2022 | -5.62x | $-5.27 Million | $938.03K | ▼ -3074.3% |
| 2021 | -0.18x | $-767.31K | $4.34 Million | ▲ +22.9% |
| 2020 | -0.23x | $-726.57K | $3.16 Million | ▼ -22.2% |
| 2019 | -0.19x | $-390.99K | $2.08 Million | ▼ -269.5% |
| 2018 | 0.11x | $409.90 Million | $3.70 Billion | ▼ -5.9% |
| 2017 | 0.12x | $410.50 Million | $3.48 Billion | ▼ -4.8% |
| 2016 | 0.12x | $434.40 Million | $3.51 Billion | ▲ +21.8% |
| 2015 | 0.10x | $349.10 Million | $3.43 Billion | ▲ +0.2% |
| 2014 | 0.10x | $346.90 Million | $3.42 Billion | ▼ -14.9% |
| 2013 | 0.12x | $346.60 Million | $2.91 Billion | ▼ -1.6% |
| 2012 | 0.12x | $353.10 Million | $2.91 Billion | ▲ +39.4% |
| 2011 | 0.09x | $259.40 Million | $2.98 Billion | ▼ -38.9% |
| 2010 | 0.14x | $410.80 Million | $2.88 Billion | ▲ +49.8% |
| 2009 | 0.10x | $270.00 Million | $2.84 Billion | ▼ -67.3% |
| 2008 | 0.29x | $800.00 Million | $2.75 Billion | ▲ +137.9% |
| 2007 | 0.12x | $304.00 Million | $2.49 Billion | ▼ -20.9% |
| 2006 | 0.15x | $386.00 Million | $2.50 Billion | ▼ -1.5% |
| 2005 | 0.16x | $387.00 Million | $2.47 Billion | ▼ -45.0% |
| 2004 | 0.28x | $476.00 Million | $1.67 Billion | ▼ -21.0% |
| 2003 | 0.36x | $373.00 Million | $1.04 Billion | — |